Skip to main content
Clinical Trials/NCT03755024
NCT03755024
Unknown
Not Applicable

Implementation of WHO Fetal Growth Charts in Assiut,Egypt

Assiut University0 sites102 target enrollmentJanuary 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fetal Growth Complications
Sponsor
Assiut University
Enrollment
102
Primary Endpoint
Proportion of fetuses with abnormal fetal growth diagnosed using WHO fetal charts
Last Updated
7 years ago

Overview

Brief Summary

Perinatal mortality and morbidity continue to be major global health challenges strongly associated with prematurity and reduced fetal growth, an issue of further interest given the mounting evidence that fetal growth in general is linked to degrees of risk of common noncommunicable diseases in adulthood. Ultrasound estimation of fetal weight before birth is today very widely used in clinical practice, and, while essential for the identification and management of high-risk pregnancies,the current reference ranges used worldwide are largely based on single populations from a few high-income countries and are therefore of uncertain general applicability.

Detailed Description

Against this background, WHO made it a high priority to provide fetal growth charts for estimated fetal weight and common ultrasound biometric measurements intended for worldwide use. WHO study was conducted in 10 countries including Egypt (Assiut).The study showed that fetal growth differs significantly between countries. Growth was to a small extent influenced by maternal age, height, weight, and parity, and by fetal sex. The study suggested that these WHO charts for growth are more suitable for international use than those commonly applied today. However, the differences between countries, with maternal factors, and with fetal sex mean that these growth charts may need to be adjusted for local clinical use to increase their diagnostic and predictive performance. In our setting, we are using the charts built in the ultrasound machines based on studies done in western countries. So, it is prudent now to implement the WHO fetal growth charts in our setting

Registry
clinicaltrials.gov
Start Date
January 2019
End Date
May 2020
Last Updated
7 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

mina eshak tawfeek khalil

Principal investigator

Assiut University

Eligibility Criteria

Inclusion Criteria

  • They have body-mass index between 18-30;
  • They have a singleton pregnancy;
  • Their gestational age at entry is between 8+0 to 12+6 weeks based on last menstrual period.
  • They have no history of health, environmental or economic constraints likely to impede fetal growth; need for long-term medication (including fertility treatment); smoking currently or in the previous 6 months; recurrent miscarriage; and any previous baby delivered pre-term (\<37 weeks) or with a birth weight \<2,500g b. Exclusion criteria:
  • Multiple pregnancy
  • Congenital fetal malformation (cardiac, cerebral, renal malformations, etc.)

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Proportion of fetuses with abnormal fetal growth diagnosed using WHO fetal charts

Time Frame: 8 months

correlation of fetal growth pattern with neonatal birth weight and outcome

Similar Trials